Barry Kay

Q: What Schools Are Affiliated With Barry Kay

Barry Kay is affiliated with the following schools: Imperial College London, University of Alberta, Free University of Berlin, University of Edinburgh, University of Cambridge, Harvard University

Barry Kay 's AcademicInfluence.com Rankings

Barry Kay

Philosophy

#2954

World Rank

#4892

Historical Rank

Logic

#870

World Rank

#1431

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Barry Kay 's Degrees

Doctorate Allergy Imperial College London

Why Is Barry Kay Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Anthony Barrington "Barry" Kay was a British immunologist known for his research in asthma and allergy. He was a professor at Imperial College London and a consultant immunologist to Royal Brompton Hospital.

(See a Problem?)

Barry Kay 's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Allergy and allergic diseases. First of two parts. (2001) (1052)
Bronchial biopsies in asthma. An ultrastructural, quantitative study and correlation with hyperreactivity. (1989) (993)
Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma. Relationship to bronchial hyperreactivity. (1988) (916)
Eosinophil's role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway. (2003) (805)
Eosinophils: Biological Properties and Role in Health and Disease (2008) (777)
Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics. (2003) (766)
Asthma and inflammation. (1991) (684)
The role of T lymphocytes in the pathogenesis of asthma. (2003) (623)
T cells and eosinophils in the pathogenesis of asthma. (1992) (599)
Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils. (1986) (595)
Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous responses. (1993) (490)
Allergy and allergic diseases. Second of two parts. (2001) (463)
Enhanced expression of eotaxin and CCR3 mRNA and protein in atopic asthma. Association with airway hyperresponsiveness and predominant co‐localization of eotaxin mRNA to bronchial epithelial and endothelial cells (1997) (445)
Lymphocytes (1991) (440)
CD4 T-lymphocyte activation in acute severe asthma. Relationship to disease severity and atopic status. (1990) (391)
Usefulness of immunotherapy in patients with severe summer hay fever uncontrolled by antiallergic drugs. (1991) (379)
IL-5 enhances the in vitro adhesion of human eosinophils, but not neutrophils, in a leucocyte integrin (CD11/18)-dependent manner. (1990) (368)
T LYMPHOCYTE ACTIVATION IN ACUTE SEVERE ASTHMA (1988) (359)
Effect of T-cell peptides derived from Fel d 1 on allergic reactions and cytokine production in patients sensitive to cats: a randomised controlled trial (2002) (358)
Trial of cyclosporin in corticosteroid-dependent chronic severe asthma (1992) (320)
Leukotrienes, LTC4 and LTB4, in bronchoalveolar lavage in bronchial asthma and other respiratory diseases. (1989) (303)
The relationship between infiltrating CD4+ lymphocytes, activated eosinophils, and the magnitude of the allergen-induced late phase cutaneous reaction in man. (1988) (297)
Neutrophil chemotactic activity in antigen-induced late asthmatic reactions. (1982) (291)
A role for eosinophils in airway remodelling in asthma. (2004) (288)
Human eosinophil, but not neutrophil, adherence to IL-1-stimulated human umbilical vascular endothelial cells is alpha 4 beta 1 (very late antigen-4) dependent. (1991) (277)
Allergy and Allergic Diseases (2001) (261)
Responses of human skin to intradermal injection of leukotrienes C4, D4 and B4 (1983) (260)
Anti-IL-5 (mepolizumab) therapy induces bone marrow eosinophil maturational arrest and decreases eosinophil progenitors in the bronchial mucosa of atopic asthmatics. (2003) (256)
Glucocorticoid resistance in chronic asthma. Glucocorticoid pharmacokinetics, glucocorticoid receptor characteristics, and inhibition of peripheral blood T cell proliferation by glucocorticoids in vitro. (1991) (252)
Eosinophils: biology and role in disease. (1995) (252)
Interleukin-5 selectively enhances the chemotactic response of eosinophils obtained from normal but not eosinophilic subjects. (1992) (251)
Adhesion to fibronectin prolongs eosinophil survival (1993) (240)
AN EOSINOPHIL LEUKOCYTE CHEMOTACTIC FACTOR OF ANAPHYLAXIS (1971) (235)
TH1/TH2 cytokines and inflammatory cells in skin biopsy specimens from patients with chronic idiopathic urticaria: comparison with the allergen-induced late-phase cutaneous reaction. (2002) (229)
A PREALBUMIN ACTIVATOR OF PREKALLIKREIN III. APPEARANCE OF CHEMOTACTIC ACTIVITY FOR HUMAN NEUTROPHILS BY THE CONVERSION OF HUMAN PREKALLIKREIN TO KALLIKREIN (1972) (229)
Allergen-induced recruitment of bronchoalveolar helper (OKT4) and suppressor (OKT8) T-cells in asthma. Relative increases in OKT8 cells in single early responders compared with those in late-phase responders. (1987) (219)
Peptide immunotherapy in allergic asthma generates IL-10–dependent immunological tolerance associated with linked epitope suppression (2009) (210)
The IgE-mediated release of an eosinophil leukocyte chemotactic factor from human lung. (1971) (210)
Eotaxin (CCL11) and Eotaxin-2 (CCL24) Induce Recruitment of Eosinophils, Basophils, Neutrophils, and Macrophages As Well As Features of Early- and Late-Phase Allergic Reactions Following Cutaneous Injection in Human Atopic and Nonatopic Volunteers1 (2002) (210)
TNFα mRNA expression in allergic inflammation (1991) (199)
Influence of albuterol, cromolyn sodium and ipratropium bromide on the airway and circulating mediator responses to allergen bronchial provocation in asthma. (2015) (198)
Activated human eosinophils generate SRS-A leukotrienes following IgG-dependent stimulation (1985) (195)
Identification and partial characterization of an exercise-induced neutrophil chemotactic factor in bronchial asthma. (1982) (194)
Complement receptor enhancement and chemotaxis of human neutrophils and eosinophils by leukotrienes and other lipoxygenase products. (1982) (189)
Exercise-induced release of histamine and neutrophil chemotactic factor in atopic asthmatics. (1982) (186)
Double-blind, placebo-controlled study of cyclosporin A as a corticosteroid-sparing agent in corticosteroid-dependent asthma. (1996) (184)
Glucocorticoid resistance in chronic asthma. Peripheral blood T lymphocyte activation and comparison of the T lymphocyte inhibitory effects of glucocorticoids and cyclosporin A. (1991) (183)
Development and preliminary clinical evaluation of a peptide immunotherapy vaccine for cat allergy. (2011) (171)
Bronchoalveolar lavage in asthma: the effect of disodium cromoglycate (cromolyn) on leukocyte counts, immunoglobulins, and complement. (1984) (169)
Overview of 'allergy and allergic diseases: with a view to the future'. (2000) (168)
CD69 is expressed by human eosinophils activated in vivo in asthma and in vitro by cytokines. (1993) (159)
Blood eosinophils and eosinophil-derived proteins in allergic asthma. (1989) (159)
T Cell Epitope Immunotherapy Induces a CD4+ T Cell Population with Regulatory Activity (2005) (158)
Exercise-induced late asthmatic reactions with neutrophil chemotactic activity. (1983) (154)
Allergen‐Induced Release of Sulphidopeptide Leukotrienes (SRS‐A) and LTB4 in Allergic Rhinitis (1985) (154)
CD4 T lymphocyte activation in acute severe asthma. (1991) (151)
Remodeling and airway hyperresponsiveness but not cellular inflammation persist after allergen challenge in asthma. (2007) (150)
Chemotaxis for Human Monocytes by Fibrinogen‐derived Peptides (1976) (142)
Preferential generation of leukotriene C4 by human eosinophils. (1984) (141)
The role of T lymphocytes in asthma. (2006) (141)
Cytokine generation by eosinophils. (1994) (140)
Induction of interleukin‐10 and suppressor of cytokine signalling‐3 gene expression following peptide immunotherapy (2006) (139)
The Relationship Between Allergen-Induced Tissue Eosinophilia and Markers of Repair and Remodeling in Human Atopic Skin1 (2002) (139)
Morphological studies on the killing of schistosomula of Schistosoma mansoni by human eosinophil and neutrophil cationic proteins in vitro (1981) (136)
T Cells and Chronic Asthma (1999) (131)
IL‐13 production by allergen‐stimulated T cells is increased in allergic disease and associated with IL‐5 but not IFN‐γ expression (1997) (130)
Acute allergen-induced airway remodeling in atopic asthma. (2004) (130)
Fc gamma and CD11/CD18 receptor expression on normal density and low density human eosinophils. (1990) (128)
Eosinophils and eosinophil-associated cytokines in allergic inflammation. (1997) (127)
Killing of schistosomula of Schistosoma mansoni coated with antibody and/or complement by human leukocytes in vitro: requirement for complement in preferential killing by eosinophils. (1979) (126)
Eosinophils and T-lymphocytes in late-phase allergic reactions. (1990) (126)
Corticosteroid resistance in chronic asthma (1981) (123)
Studies on eosinophil leucocyte migration. II. Factors specifically chemotactic for eosinophils and neutrophils generated from guinea-pig serum by antigen-antibody complexes. (1970) (123)
The effect of Fel d 1‐derived T‐cell peptides on upper and lower airway outcome measurements in cat‐allergic subjects (2005) (119)
Eosinophil activation and T lymphocyte infiltration in allergen-induced late phase skin reactions and classical delayed-type hypersensitivity. (1991) (118)
Interleukin 5 regulates the isoform expression of its own receptor alpha-subunit. (2000) (118)
T lymphocytes and eosinophils in allergen-induced late-phase asthmatic reactions in the guinea pig. (1990) (117)
"Helper" (CD4+) T cells and eosinophils in allergy and asthma. (1992) (116)
The role of the eosinophil in the pathogenesis of asthma (1987) (115)
IFN-gamma induces expression of Fc gamma RIII (CD16) on human eosinophils. (1992) (113)
Interleukin‐8 is a chemo‐attractant for eosinophils purified from subjects with a blood eosinophilia but not from normal healthy subjects (1993) (112)
Corticosteroid resistance in chronic asthma. (1981) (109)
Mechanisms of persistent airway inflammation in asthma. A role for T cells and T-cell products. (1995) (108)
Allergen‐induced fluctuation in CC chemokine receptor 3 expression on bone marrow CD34+ cells from asthmatic subjects: significance for mobilization of haemopoietic progenitor cells in allergic inflammation (2003) (108)
Activin-A induces regulatory T cells that suppress T helper cell immune responses and protect from allergic airway disease (2009) (104)
Eosinophils as effector cells in immunity and hypersensitivity disorders. (1985) (100)
Elevations in T‐helper‐2‐initiating cytokines (interleukin‐33, interleukin‐25 and thymic stromal lymphopoietin) in lesional skin from chronic spontaneous (‘idiopathic’) urticaria (2015) (99)
IDENTIFICATION OF LEUKOTRIENES D AND B IN SPUTUM FROM CYSTIC FIBROSIS PATIENTS (1981) (98)
Anti-IgE (omalizumab) inhibits late-phase reactions and inflammatory cells after repeat skin allergen challenge. (2005) (96)
Application of monoclonal antibodies against major basic protein (BMK‐13) and eosinophil cationic protein (EG1 and EG2) for quantifying eosinophils in bronchial biopsies from atopic asthma (1992) (96)
Intravenous anti-IL-5 monoclonal antibody reduces eosinophils and tenascin deposition in allergen-challenged human atopic skin. (2004) (95)
European allergy white paper: allergic diseases as a public health problem in Europe (1997) (95)
Influence of prolonged treatment with topical corticosteroid (fluticasone propionate) on early and late phase nasal responses and cellular infiltration in the nasal mucosa after allergen challenge (1994) (93)
Sputum cysteinyl leukotrienes increase 24 hours after allergen inhalation in atopic asthmatics. (2000) (93)
The accumulation of 111In-eosinophils induced by inflammatory mediators, in vivo. (1991) (93)
The roles of inflammatory cells in the pathogenesis of asthma and of chronic obstructive pulmonary disease. (1991) (93)
Intracellular localization of interleukin-6 in eosinophils from atopic asthmatics and effects of interferon gamma. (1998) (90)
Adhesion to fibronectin primes eosinophils via alpha 4 beta 1 (VLA-4). (1994) (90)
Interleukin‐10 levels increase in cutaneous biopsies of patients undergoing wasp venom immunotherapy (2001) (88)
T lymphocytes and their products in atopic allergy and asthma. (1991) (88)
Effects of nedocromil sodium (Tilade®) on the activation of human eosinophils and neutrophils and the release of histamine from mast cells (1988) (88)
Selective attraction of eosinophils and synergism between eosinophil chemotactic factor of anaphylaxis (ECF-A) and a fragment cleaved from the fifth component of complement (C5a). (1973) (87)
Human eosinophils express messenger RNA encoding RANTES and store and release biologically active RANTES protein (1996) (86)
Identification of interleukin-2 in human peripheral blood eosinophils. (1996) (86)
The role of eosinophils in the pathogenesis of asthma. (2005) (86)
The chemotactic activity for neutrophil and eosinophil leucocytes of the trimolecular complex of the fifth, sixth and seventh components of human complement (C567) prepared in free solution by the 'reactive lysis' procedure. (1970) (85)
Bone Morphogenetic Protein (BMP)-4 and BMP-7 regulate differentially Transforming Growth Factor (TGF)-β1 in normal human lung fibroblasts (NHLF) (2010) (83)
Membrane receptors for IgG and complement (C4, C3b and C3d) on human eosinophils and neutrophils and their relation to eosinophilia. (1977) (82)
Association of granulocyte-macrophage colony-stimulating factor with the crystalloid granules of human eosinophils. (1995) (82)
Sputum leukotrienes in obstructive airways diseases. (1984) (81)
Leucoattractants enhance complement receptors on human phagocytic cells. (1979) (79)
The Identification of Fibrinopeptide B as a Chemotactic Agent Derived from Human Fibrinogen (1974) (78)
Elevations in vascular markers and eosinophils in chronic spontaneous urticarial weals with low-level persistence in uninvolved skin (2014) (78)
MHC class II restriction specificity of cloned human T lymphocytes reactive with Dermatophagoides farinae (house dust mite). (1988) (78)
Cat allergen peptide immunotherapy reduces CD4+ T cell responses to cat allergen but does not alter suppression by CD4+ CD25+ T cells: a double‐blind placebo‐controlled study (2004) (78)
The effect of dexamethasone, cyclosporine, and rapamycin on T-lymphocyte proliferation in vitro: comparison of cells from patients with glucocorticoid-sensitive and glucocorticoid-resistant chronic asthma. (1994) (76)
Peptide-Mediated Immune Responses in Specific Immunotherapy (2000) (74)
Eosinophils and neutrophils (1984) (74)
Pathology of mild, severe, and fatal asthma. (1996) (73)
Late asthmatic reactions induced by inhalation of allergen-derived T cell peptides. (2004) (71)
Activin and transforming growth factor-beta signaling pathways are activated after allergen challenge in mild asthma. (2009) (70)
THE LINK BETWEEN EXERCISE, RESPIRATORY HEAT EXCHANGE, AND THE MAST CELL IN BRONCHIAL ASTHMA (1983) (69)
Adoptive transfer of allergen‐specific CD4+ T cells induces airway inflammation and hyperresponsiveness in Brown–Norway rats (1997) (68)
Relationship between mediator release from human lung mast cells in vitro and in vivo. (1985) (67)
The early history of the eosinophil (2015) (67)
Cloned human T lymphocytes reactive with Dermatophagoides farinae (house dust mite): a comparison of T- and B-cell antigen recognition. (1987) (67)
Mediators of Hypersensitivity and “Fog”‐Induced Asthma (1985) (67)
Increased expression of mRNA encoding RANTES and MCP-3 in the bronchial mucosa in atopic asthma. (1996) (65)
Corticosteroid-resistant chronic asthma and monocyte complement receptors. (1981) (65)
Effects of inhaled PAF in humans on circulating and bronchoalveolar lavage fluid neutrophils. Relationship to bronchoconstriction and changes in airway responsiveness. (1990) (65)
Human eosinophil- and neutrophil-mediated killing of schistosomula of Schistosoma mansoni in vitro. I. Enhancement of complement-dependent damage by mast cell-derived mediators and formyl methionyl peptides. (1980) (63)
Mast cells, mediators and asthma (1985) (63)
Eosinophil cationic protein(ECP) and eosinophil protein X (EXP) concentrations in serum and bronchial lavage fluid in asthma. effect of prednisolone treatment. (1995) (63)
The ECF-A tetrapeptides and histamine selectively enhance human eosinophil complement receptors (1977) (63)
Immunotherapy and allergic inflammation (1991) (61)
MEDIATORS OF IMMEDIATE-TYPE HYPERSENSITIVITY IN SPUTUM FROM PATIENTS WITH CHRONIC BRONCHITIS AND ASTHMA (1977) (61)
Inhaled glucocorticoid therapy of childhood asthma is associated with reduced peripheral blood T cell activation and 'Th2-type' cytokine mRNA expression. (1997) (61)
Airway hyperresponsiveness, elevation of serum-specific IgE and activation of T cells following allergen exposure in sensitized Brown-Norway rats. (1995) (59)
Elevated expression of interleukin‐9 mRNA in the bronchial mucosa of atopic asthmatics and allergen‐induced cutaneous late‐phase reaction: relationships to eosinophils, mast cells and T lymphocytes (2002) (58)
An in vitro model of allergen-dependent IgE synthesis by human B lymphocytes: comparison of the response of an atopic and a non-atopic individual to Dermatophagoides spp. (house dust mite). (1989) (58)
Chemotaxis of human basophil leucocytes. (1972) (57)
Intracellular application of guanosine-5'-O-(3-thiotriphosphate) induces exocytotic granule fusion in guinea pig eosinophils (1990) (57)
Molecular concepts of IgE‐initiated inflammation in atopic and nonatopic asthma (1998) (57)
Release of leukotrienes during rapid expulsion of Trichinella spiralis from immune rats. (1987) (57)
Role of T-lymphocytes and lymphokines (1992) (57)
Nedocromil, a mucosal and connective tissue mast cell stabilizer, inhibits exercise-induced asthma. (1985) (57)
Serum interleukin 5 concentrations in atopic and non-atopic patients with glucocorticoid-dependent chronic severe asthma. (1994) (56)
Interleukin-5 enhances the in vitro adhesion of human eosinophils, but not neutrophils, in a leucocyte integrin (CD11/18)-dependent manner. (1991) (56)
Mediators in exercise-induced asthma. (1984) (55)
TH2‐Type Cytokines in Asthma (1996) (54)
Inhibition of platelet-activating factor (PAF)-induced chemotaxis and PAF binding to human eosinophils and neutrophils by the specific ginkgolide-derived PAF antagonist, BN 52021. (1989) (54)
Interaction between isoprenaline and aminophylline in asthma (1977) (54)
Eosinophils and asthma. (1991) (53)
Receptor expression and functional status of cultured human eosinophils derived from umbilical cord blood mononuclear cells. (1990) (52)
T cells as orchestrators of the asthmatic response. (1997) (51)
IgG-dependent generation of platelet-activating factor by normal and low density human eosinophils. (1990) (51)
Eosinophils and interleukin-5: the debate continues. (2003) (50)
Asthma : clinical pharmacology and therapeutic progress (1986) (49)
Early production of thymic stromal lymphopoietin precedes infiltration of dendritic cells expressing its receptor in allergen‐induced late phase cutaneous responses in atopic subjects (2009) (49)
Basal expression of bone morphogenetic protein receptor is reduced in mild asthma. (2008) (49)
Studies on eosinophil leucocyte migration. I. Eosinophil and neutrophil accumulation following antigen-antibody reactions in guinea-pig skin. (1970) (47)
Comparison of the immunopathology of extrinsic, intrinsic and occupational asthma. (1994) (47)
Activated peripheral blood CD4 and CD8 T‐lymphocytes in child asthma: correlation with eosinophilia and disease severity (1994) (47)
Effects of prolonged repeated exposure to ovalbumin in sensitized brown Norway rats. (1994) (47)
The role of the eosinophil. (1979) (46)
The generation of chemotactic activity for human leukocytes by the action of plasmin on human fibrinogen. (1975) (45)
Neutrophil chemotactic activity and histamine in atopic and nonatopic subjects after exercise-induced asthma. (1984) (45)
The pattern of human late-phase skin reactions to extracts of aeroallergens. (1988) (45)
Anti-interleukin-5 therapy for asthma and hypereosinophilic syndrome. (2004) (44)
Effects of rapamycin, cyclosporin A, and dexamethasone on interleukin 5‐induced eosinophil degranulation and prolonged survival (1997) (44)
Eosinophil Development and Bone Marrow and Tissue Eosinophils in Atopic Asthma (1999) (44)
Activation of the classical and alternate pathways of complement by Corynebacterium parvum. (1975) (44)
Eosinophils in Allergy and Inflammation (1994) (44)
Skin reactivity and local cell recruitment in human atopic and nonatopic subjects by CCL2/MCP‐1 and CCL3/MIP‐1α (2008) (43)
Mechanisms of granule enzyme secretion from permeabilized guinea pig eosinophils. Dependence on Ca2+ and guanine nucleotides. (1991) (43)
Enhancement of neutrophil- and eosinophil-mediated complement-dependent killing of schistosomula of Schistosoma mansoni in vitro by leukotriene B4. (1983) (43)
Interactions between eotaxin, histamine and mast cells in early microvascular events associated with eosinophil recruitment to the site of allergic skin reactions in humans (2004) (43)
IL‐5 production by allergen‐stimulated T cells following grass pollen immunotherapy for seasonal allergic rhinitis (1997) (43)
Polymerase chain reaction quantification of cytokine messenger RNA expression in peripheral blood mononuclear cells of patients with acute exacerbations of asthma: effect of glucocorticoid therapy (1994) (43)
The effect of a single oral dose of prednisolone or cetirizine on inflammatory cells infiltrating allergen‐induced cutaneous late‐phase reactions in atopic subjects (1992) (41)
Effects of cetirizine on human eosinophil and neutrophil activation in vitro. (1991) (41)
Anti-T cell strategies in asthma (1999) (41)
Glucocorticoid resistant asthma: T-lymphocyte steroid metabolism and sensitivity to glucocorticoids and immunosuppressive agents. (1996) (40)
Identification of guinea pig eosinophil chemotactic factor of anaphylaxis as leukotriene B4 and 8(S),15(S)-dihydroxy-5,9,11,13(Z,E,Z,E)-eicosatetraenoic acid. (1991) (40)
Widespread IgE-mediated hypersensitivity in Northern Sudan to the chironomid Cladotanytarsus lewisi ('green nimitti'). (1978) (40)
Eosinophil chemotaxis of supernatants from cultured Hodgkin's lymph node cells. (1975) (39)
Leukotrienes and lung disease. (1982) (39)
Human eosinophils, acidic tetrapeptides (ECF-A) and histamine. Interactions in vitro and in vivo. (1977) (39)
Evidence for Th2-type T helper cell control of allergic disease in vivo (2004) (39)
Release of leukotriene C4 (LTC4) from human eosinophils following adherence to IgE- and IgG-coated schistosomula of Schistosoma mansoni. (1990) (39)
The effect of corticosteroids on monocyte and neutrophil activation in bronchial asthma. (1985) (38)
Asthma. Eosinophils and neutrophils. (1992) (38)
Effect of inhaled interleukin‐5 on eosinophil progenitors in the bronchi and bone marrow of asthmatic and non‐asthmatic volunteers (2007) (38)
Neutrophil chemotactic factor in exercise- and hyperventilation-induced asthma. (1983) (38)
Widespread immunoglobulin E-mediated hypersensitivity in the Sudan to the "green nimitti" midge, Cladotanytarsus lewisi (diptera: Chironomidae). (1980) (36)
The effects of an ECF-A and formyl methionyl chemotactic peptides on oxidative metabolism of human eosinophils and neutrophils. (1981) (36)
Complement components and IgE in bronchial asthma. (1974) (36)
Leucocytes in asthma. (1988) (36)
SLOW-REACTING SUBSTANCE OF ANAPHYLAXIS ANTAGONIST FPL 55712 IN CHRONIC ASTHMA (1981) (36)
Modulation of human eosinophil chemotaxis and adhesion by anti‐allergic drugs in vitro (1993) (35)
Enteral and systemic release of leukotrienes during anaphylaxis of Nippostrongylus brasiliensis-primed rats. (1986) (35)
The effect of platelet-activating factor on IgE binding to, and IgE-dependent biological properties of, human eosinophils. (1990) (35)
Mast cells in human lungs (1989) (33)
Increases in eotaxin‐positive cells in induced sputum from atopic asthmatic subjects after inhalational allergen challenge (1999) (33)
Calcitonin gene‐related peptide and vascular endothelial growth factor are expressed in lesional but not uninvolved skin in chronic spontaneous urticaria (2014) (32)
Binding of immunoglobulin classes and subclasses to human neutrophils and eosinophils. (1986) (32)
INHIBITION OF HUMAN GRANULOCYTE ACTIVATION BY NEDOCROMIL SODIUM (1986) (32)
T‐lymphocytes, allergy and asthma (1991) (32)
Neutrophil chemotactic factor of anaphylaxis. (1982) (32)
UCHL1+ (CD45RO+)‘memory’T cells predominate in the CD4+ cellular infiltrate associated with allergen‐induced late‐phase skin reactions in atopic subjects (1991) (31)
Histamine-coated particles generate Superoxide (O−2) and chemiluminescence in alveolar macrophages (1979) (31)
The prevalence of asthma and rhinitis in a Sudanese community seasonally exposed to a potent airborne allergen (the "green nimitti" midge, Cladotanytarsus lewisi). (1983) (31)
Airways reversibility after prednisolone therapy in chronic asthma is associated with alterations in leukocyte function. (1985) (30)
FUNCTIONS OF THE EOSINOPHIL LEUCOCYTE (1976) (30)
CCL17/thymus and activation-regulated chemokine induces calcitonin gene-related peptide in human airway epithelial cells through CCR4. (2013) (30)
Evidence for haemoglobins as common allergenic determinants in IgE‐mediated hypersensitivity to chironomids (non‐biting midges) (1985) (30)
Airway hyperresponsiveness and bronchial mucosal inflammation in T cell peptide-induced asthmatic reactions in atopic subjects (2007) (29)
Interleukin-3-induced up-regulation of CR3 expression on human eosinophils is inhibited by dexamethasone. (1992) (29)
Human late asthmatic reactions (1997) (29)
Airway expression of calcitonin gene‐related peptide in T‐cell peptide‐induced late asthmatic reactions in atopics (2007) (29)
Inflammatory cells in bronchial asthma. (1989) (29)
Immunologic release of neutrophil chemotactic activity from human lung tissue. (1983) (28)
100 years of ‘Allergy’: can von Pirquet's word be rescued? (2006) (27)
The Eosinophil in Infectious Diseases (1974) (27)
Neutrophil chemotactic activity in milk-induced asthma. (1983) (26)
Enhanced expression of human monocyte complement (C3b) receptors by chemoattractants. (1980) (26)
A PREALBUMIN ACTIVATOR OF PREKALLIKREIN (1972) (26)
Chironomid midges as a cause of allergy in the Sudan. (1981) (26)
The topical glucocorticoids beclomethasone dipropionate and fluticasone propionate inhibit human T‐cell allergen‐induced production of IL‐5, IL‐3 and GM‐CSF mRNA and protein (2001) (26)
Alternative allergy and the General Medical Council. (1993) (26)
T-cell/eosinophil interactions in the induction of asthma. (1996) (26)
Inflammatory cells in acute and chronic asthma. (2015) (25)
Schistosoma mansoni: complement and antibody damage, mediated by human eosinophils and neutrophils, in killing schistosomula in vitro. (1981) (25)
Chemotactic factor-induced enhancement of the binding of human immunoglobulin classes and subclasses to neutrophils and eosinophils. (1984) (25)
T lymphocytes in allergen-induced late-phase reactions and asthma. (1989) (24)
Immediate-type skin reactivity to extracts of the 'green nimitti' midge, (Cladotanytarsus lewisi), and other chironomids in asthmatic subjects in the Sudan and Egypt. (1983) (24)
Cyclosporin A, apoptosis of BAL T‐cells and expression of Bcl‐2 inasthmatics (2003) (24)
Calcitonin gene-related peptide- and vascular endothelial growth factor-positive inflammatory cells in late-phase allergic skin reactions in atopic subjects. (2011) (24)
Cutaneous eosinophil accumulation in atopic and non‐atopic individuals: the effect of an ECF‐A tetrapeptide and histamine (1977) (24)
VARIATIONS IN CHEMICAL MEDIATORS OF HYPERSENSITIVITY IN THE SPUTUM OF CHRONIC BRONCHITICS: CORRELATION WITH PEAK EXPIRATORY FLOW (1978) (24)
Leucocyte Function in a Case of Chronic Benign Neutropenia of Infancy Associated with Circulating Leucoagglutinins (1976) (23)
Monocyte function in cancer patients. (1977) (23)
Antigen-induced neutrophil chemotactic factor from cloned human T lymphocytes. (1988) (23)
Paul Ehrlich and the Early History of Granulocytes. (2016) (23)
Asthma. Role of T-lymphocytes and lymphokines. (1992) (22)
Origin of type 2 helper T cells. (1994) (22)
Role of Th1 and Th2 cells in human allergic disorders. (1996) (22)
Clinical response to cyclosporin in chronic severe asthma is associated with reduction in serum soluble interleukin-2 receptor concentrations. (1995) (21)
Airway expression of calcitonin gene-related peptide in T-cell peptide-induced late asthmatic reactions in atopics. (2006) (21)
Neutrophil chemotactic activity in acute severe asthma (status asthmaticus). (1987) (21)
Macrophage inflammatory protein‐1α and C–C chemokine receptor‐1 in allergen‐induced skin late‐phase reactions: relationship to macrophages, neutrophils, basophils, eosinophils and T lymphocytes (2001) (21)
The role of cellular immunology in asthma. (1991) (21)
CHEMOTAXIS AND HAEMOSTASIS (1975) (21)
Widespread IgE-mediated hypersensitivity in the Sudan to the 'green nimitti' midge, Cladotanytarsus lewisi (Diptera: Chironomidae) II. Identification of a major allergen. (1980) (20)
Influence of atopy on the clinical manifestations of coronavirus infection in adult volunteers (1988) (20)
The activated eosinophil in allergy and asthma. (1989) (20)
Psychopharmacological studies on (-)-nuciferine and its Hofmann degradation product atherosperminine (1978) (20)
Expression of eotaxin in induced sputum of atopic and nonatopic asthmatics (2000) (20)
Peptide-based vaccines in the treatment of specific allergy. (2002) (20)
The identification and partial characterization of a human mononuclear cell-derived neutrophil chemotactic factor apparently distinct from IL-1, IL-2, GM-CSF, TNF and IFN-gamma. (1988) (19)
The mode of action of anti‐allergic drugs (1987) (19)
Enhancement of leukocyte cytotoxicity after exercise-induced asthma. (1986) (19)
Methods for Identifying Human Eosinophils in Blood and Tissue (2002) (19)
Leukotriene C4 generation from human eosinophils stimulated with IgG-Aspergillus fumigatus antigen immune complexes. (1988) (19)
Monocyte chemotaxis in bronchial carcinoma and cigarette smokers. (1977) (19)
144 Airway hyperreactivity and mediator release in clinical models of asthma (1985) (18)
Generation of chemotactic activity for leukocytes by the action of thrombin on human fibrinogen. (1973) (18)
Mediators of hypersensitivity and inflammatory cells in the pathogenesis of bronchial asthma. (1983) (18)
The Effect of Transfer Factor on Neutrophil Function in Chronic Mucocutaneous Candidiasis (1976) (18)
H1-receptor dependence of histamine-induced enhancement of human eosinophil C3b rosettes. (1980) (18)
Identification of leukotrienes in the sputum of patients with cystic fibrosis. (1982) (17)
Natural killer T cells and asthma. (2006) (17)
Allergy and inflammation (1987) (17)
Neutrophil Accumulation in Vivo following the Administration of Chemotactic Factors (1977) (17)
Role of T cells in asthma. (1998) (17)
Mediators and inflammatory cells in allergic disease. (1987) (16)
Unstimulated basophils in atopic and nonatopic subjects express intracellular interleukin‐4: detection by flow cytometry (1998) (16)
Immunohistology of human allergic late-phase skin reactions. (1991) (15)
Immunomodulation in asthma: mechanisms and possible pitfalls. (2003) (15)
Enhancement of human neutrophil complement receptors: a comparison of the rosette technique with the uptake of radio-labelled anti-CR1 monoclonal antibody. (1985) (15)
Persistence of hemoglobin allergenicity and antigenicity during metamorphosis of Chironomidae (Insecta: Diptera). (1986) (15)
Human granulocyte/pollen-binding protein. Recognition and identification as transferrin. (1984) (14)
Allergy. Conventional and alternative concepts. A report of the Royal College of Physicians Committee on Clinical Immunology and Allergy. (1992) (14)
Eosinophils 1992. (1992) (14)
Immunoglobulins and complement in pleural effusions associated with bronchogenic carcinoma. (1976) (14)
Mechanisms in asthma using the technique of bronchoalveolar lavage. (1987) (14)
Biological properties of eosinophils (1991) (14)
Allergy and asthma : new trends and approaches to therapy (1989) (13)
The effects of eosinophil activating factor on IgG-dependent sulphidopeptide leukotriene generation by human eosinophils. (1986) (13)
Enhancement of human eosinophil- and neutrophil-mediated killing of schistosomula of Schistosoma mansoni by reversed type (IgE-mediated) anaphylaxis, in vitro. (1985) (13)
The effect of anti-eosinophil serum on skin histamine replenishment following passive cutaneous anaphylaxis in the guinea-pig. (1976) (13)
Histamine receptors on guinea-pig alveolar macrophages: chemical specificity and the effects of H1- and H2-receptor agonists and antagonists. (1979) (13)
Leukotriene release enhancing factor. Purification, specific allergen induction, and further biologic properties. (1989) (12)
Complement components and IgE in patients with asthma and aspirin idiosyncrasy. (1976) (12)
Leukotriene B4 generation by human neutrophils following IgG-dependent stimulation. (1987) (12)
Lymphocytes in asthma. (1991) (12)
Expression of functional receptor activity modifying protein 1 by airway epithelial cells with dysregulation in asthma. (2010) (12)
Notice of duplicate publication. (1997) (12)
Identification on receptors for leukotriene B4 expressed on guinea-pig peritoneal eosinophils. (1992) (12)
Mechanisms of T Cell Peptide Epitope-Dependent Late Asthmatic Reactions (2001) (12)
ALLERGEN-SPECIFIC IgG4 IN BRONCHIAL ASTHMA (1982) (12)
Can clinical response to cyclosporin in chronic severe asthma be predicted by an in vitro T-lymphocyte proliferation assay? (1996) (12)
Antigen-antibody induced cutaneous eosinophilia in complement deficient guinea-pigs. (1972) (12)
159 The ginkgolide (BN 52021) inhibits PAF-induced chemotaxis and specific binding to human eosinophils and neutrophils (1988) (11)
T Cells, Cytokines and Asthma (1994) (11)
Metabolic studies on the uptake of [14C]-histidine and [14C]-histamine and histamine synthesis by guinea-pig basophils, in vitro. (1979) (11)
NEUTROPENIA AND THROMBOCYTOPENIA AFTER REPEATED COURSES OF LEUCOCYTE INTERFERON (1978) (11)
Further characterisation of allergens associated with hypersensitivity to the “green nimitti” midge (Cladotanytarsus lewisi, Diptera: Chironomidae) (1987) (11)
Defective chemotactic factor-induced monocyte complement receptor enhancement in lung cancer. (1983) (10)
Mediators of hypersensitivity in the sputum of young, symptomatic cigarette smokers (1981) (10)
Discovery and development of somatostatin agonists. (1998) (10)
Asthma, physiology, immunopharmacology, and treatment : second international symposium (1977) (10)
Cultured peripheral blood mononuclear cells derived from patients with acute severe asthma ("status asthmaticus") spontaneously elaborate a neutrophil chemotactic activity distinct from interleukin-8. (1991) (10)
ABC of allergies: Good allergy practice (1998) (10)
Inhibition of eosinophil chemotaxis by the antagonist of slow reacting substance of anaphylaxis—compound FPL 55712 * (1974) (10)
The potential of peptide immunotherapy in allergy and asthma (2002) (10)
Effect of intravenous administration of an anti-IL-5 mAb (Mepolizumab) on allergen-induced tissue eosinophilia, the late-phase allergic reaction and the expression of a marker of repair/remodeling in human atopic subjects (2003) (9)
Passive sensitization of tissue cells. 3. A primate macrophage-cytophilic antibody. (1970) (9)
Tissue inactivation of slow reacting substance of anaphylaxis. (1976) (9)
Slow reacting substance as a preformed mediator from human lung. (1976) (9)
Chemotactic factor-induced low density neutrophils express enhanced complement (CR1 and CR3) receptors and increased complement-dependent cytotoxicity. (1987) (9)
Inflammatory Cells in Allergic Disease (1988) (9)
Allergy and Hypersensitivity: History and Concepts (2009) (8)
Inhibition of re-expression of surface CD4, but not CD8, on activated human T-lymphocytes by the immunosuppressive drugs dexamethasone and cyclosporine A: correlation with inhibition of proliferation. (1996) (8)
Histamine receptors on human peripheral blood leucocytes. (1981) (8)
Modulation of eosinophil function in vitro (1990) (8)
The eosinophil in infection diseases. (1974) (7)
Failure Co detect deposition of complement and immunoglobulin in allergen‐induced late‐phase skin reaction in atopic subjects (1991) (7)
The Requirements for Transferrin‐Dependent Adherence of Human Granulocytes to Pollen Grains (1986) (7)
Anti-IL-5 (Mepolizumab) reduces the expression of tenascin, procollagen III and lumican in the reticular basement membrane of human atopic asthmatics* (2003) (7)
EXERCISE-INDUCED ASTHMA AND THE MAST CELL (1983) (7)
Partial characterization of allergens associated with hypersensitivity to the ‘green nimitti’ midge (Cladotanytarsus lewisi, Diptera: Chironomidae) (1984) (7)
Inhibition of leukotriene C4 and B4 generation by human eosinophils and neutrophils with the lipoxygenase pathway inhibitors U60257 and BW755C. (1985) (6)
Histamine increases histidine uptake by basophils. (1980) (6)
HLA class II restriction specificity of Dermatophagoides spp. reactive T lymphocyte clones that support IgE synthesis (1989) (6)
Passive sensitization of guinea-pig skin in vitro for the antigen-induced release of anaphylactic mediators. (1974) (6)
Allergy and allergic diseases. Volume 1: the scientific basis of allergy. (2008) (6)
T Lymphocytes and asthma (1991) (6)
Immunoglobulins, complement and arylsulphatase in sputum from chronic bronchitis and other pulmonary diseases. (1978) (6)
The cells causing airway inflammation. (1986) (6)
Platelet activating factor enhances eosinophil cytotoxicity in vitro (1986) (6)
Immunosuppressive agents in chronic severe asthma. (1994) (6)
Natural history of asthma from childhood to adulthood (2002) (6)
173 Eosinophils, non-specific bronchial responsiveness, and allergen-induced late-phase asthmatic reactions (1985) (6)
The orally administered anti-allergic agent, sodium nivimedone (BRL 10833); efficacy in bronchial asthma and effects on IgE, complement and eosinophils. (1979) (5)
Complement receptor enhancement by chemotactic factors. (1982) (5)
Bronchoalveolar mast cells in extrinsic asthma (1985) (5)
Drug effects on exercise-induced late asthmatic responses. (1988) (5)
229 Release of high molecular weight neutrophil chemotactic activity (NCA) from immunologically challenged human lung fragments (1983) (5)
Current perspectives in allergy (1982) (5)
Leucocytes and the asthma process. (1986) (5)
Are you TH‐l or TH‐2? (1995) (5)
T Lymphocytes in Chronic Asthma (1998) (5)
T cell peptide epitope immunotherapy is accompanied by local increases in CD25+T cells (2002) (5)
Cell-mediated immune response in asthma. (1989) (5)
Eosinophils, allergy and asthma (1990) (5)
The cells and mediators of allergic inflammation (2002) (5)
640 Immunotherapy suppresses T lymphocyte infiltration in the cutaneous late-phase reaction (1991) (5)
The effects of picumast on human eosinophil and neutrophil activation (1991) (4)
Neutrophil chemotactic factor and exercise-induced asthma. (1983) (4)
Receptor associated defects of cultured monocytes in bronchial carcinoma. (1984) (4)
Clonal analysis of the cellular immune response to the house dust mite Dermatophagoides farinae. (1989) (4)
Enhanced granulocyte cytotoxicity by mediators derived from anti-IgE-stimulated human leucocytes. (1986) (4)
The effect of enzyme digestions on the activity of eosinophil chemotactic factor of anaphylaxis (EFC-A). (1975) (4)
The contribution of inflammatory cells to the pathogenesis of asthma (1991) (4)
45 Mediators from IgE-dependent reactions that enhance eosinophil- and neutrophil-mediated complement-dependent killing of schistosomula of S. Mansoni (1985) (4)
Basic mechanisms in allergic asthma. (1982) (4)
Late‐Phase Allergic Reactions in Humans (2009) (4)
A monocyte function test (complement receptor enhancement) to assess the extent of bronchial carcinoma. (1987) (4)
T Lymphocytes and Their Products in Chronic Asthma (1990) (4)
Allergen-specific IgG-4 in bronchial asthma. (1982) (3)
Provoked asthma and mast cells. (1987) (3)
158 IgE-dependent release of leukotriene (LT) C4 from human low density eosinophils (1988) (3)
Neutrophil chemotactic factor of anaphylaxis. (1982) (3)
Induction of Antigen-Specific Late Asthmatic Reactions Precede the Allergen-Derived T Cell Peptide-Induced (2001) (3)
Activated peripheral-blood cd4 and cd8 lymphocytes-t (t-lc) in childhood asthma (1993) (3)
MONOCYTE FUNCTION IN CHRONIC BENIGN NEUTROPENIA (1975) (3)
Allergen-based peptide immunotherapy is associated with functional modifications in allergen-specific T-cell subpopulations (2004) (3)
Principles and Practice of Diagnosis and Treatment of Allergic Disease (2009) (3)
Enhancement of the expression of eosinophil IgE receptor (Fc epsilon R2) and its function by platelet-activating factor. (1990) (3)
Allergens of The ‘Green Nimitti’ Midge (1983) (3)
Inhalation of allergen-derived T cell peptide epitopes induces isolated late asthmatic reactions with associated local eosinophilia (2002) (3)
Chemotactic activity of guinea pig eosinophils for the ECF-A acidic tetrapeptides, histamine, histamine metabolites, and the effect of H1- and H2-receptor antagonists. (1977) (3)
Eosinophils in repair and remodelling (2004) (3)
Mechanism of antigen-induced late asthmatic reactions. (1983) (3)
Eosinophil and Neutrophil Membrane Receptors (1983) (3)
Inflammatory cells in chronic asthma. (1989) (3)
Landmarks in Allergy during the 19th Century. (2014) (3)
Peripheral Blood T Lymphocyte Activation and Comparison of the T Lymphocyte Inhibitory Effects of Glucocorticoids and Cyclosporin A1-3 (1991) (3)
Humoral and Cellular Mechanisms of Airway Inflammation (1990) (3)
Desensitization (“Tolerance”) induced by allergen-derived T cell peptide epitopes: Evidence for the induction of linked suppression (2002) (3)
Allergy: Conventional and Alternative Concepts (1992) (3)
354 Histamine release from mucosal-type human lung mast cells (1985) (3)
EOSINOPHILS AND ASTHMA. AUTHORS' REPLY (1991) (2)
Are you TH-1 or TH-2? (1995) (2)
Professor Robin Coombs FRS (1921-2006). (2006) (2)
Leukocyte chemotactic factors and the C3b receptor. (1981) (2)
Inhibition of monocyte complement receptor enhancement by low molecular weight material from human lung cancers. (1981) (2)
95 T-lymphocyte activation in acute severe asthma: implications for disease pathogenesis and management (1988) (2)
ENHANCED NEUTROPHIL AND MONOCYTE CYTO-TOXICITY AFTER EXERCISE INDUCED ASTHMA (1985) (2)
An extract of Timothy-grass pollen used as sublingual immunotherapy for summer hay fever. (2007) (2)
The relationship of infiltrating eosinophils to markers of repair and resolution (myofibroblasts, TGF-β and tenascin) in allergen-induced late-phase reactions in human skin (2002) (2)
Neutrophil Chemotactic Activity in the Late Phase Bronchial Obstruction (1985) (2)
Peptide therapy and asthma. (2004) (2)
Current Perspectives in the Immunology of Respiratory Diseases (1986) (2)
Effect of HLA-DR-based T cell peptides derived from phospholipase A2 on late-phase skin reactions and T cell function in subjects with mild honeybee allergy (2003) (2)
Th1/Th2 cytokines and cell infiltration in skin from chronic idiopathic urticaria: Comparison with allergen-induced skin late-phase reactions and normal controls (2002) (2)
Late asthmatic reactions provoked by intradermal, but not inhaled, allergen-derived T-cell peptides induce “Tolerance” to subsequent antigen challenge (2003) (2)
Alternative allergy and the GMC (1993) (2)
In Vitro Effects of Chemotactic Factors on Eosinophil Fc and Complement Receptor Expression (1987) (2)
111 Attenuation of late cutaneous and asthmatic reactions following administration of short allergen-derived T cell peptide epitopes (2000) (2)
Airway Submucosal Cells Expressing TGF-β1Are Significantly Increased at a Time Point When Airway Remodelling Is Maximal Post-Allergen. (2009) (2)
361 Influence of salbutamol and sodium cromoglycate on mast cell mediator release in vivo (1985) (1)
768 The effect of prednisolone and cetirizine on the immunohistology of allergen-induced late skin responses (1991) (1)
The effects of T cell peptides in patients sensitive to cats (2004) (1)
A T-lymphocyte-derived factor that enhances IgG-dependent release of leukotriene B4 (LTB4) from human neutrophils. (1988) (1)
Mediators of immediate type hypersensitivity in sputum from symptomatic young cigarette smokers. (1979) (1)
379 Effects of dexamethasone, cyclosporine A and rapamycin on eosinophil degranulation and survival (1996) (1)
Title: Airway Hyperresponsiveness and Bronchial Mucosal Inflammation in T- Cell Peptide-induced Asthmatic Reactions in Atopic Subjects Running title: AHR, T Cells and Late Asthmatic Reactions (2007) (1)
Clinical, Entomological and Epidemiological Studies on Allergy to a Non-Biting Midge Cladotanytarsus Lewisi (Green Nimitti) (1983) (1)
The Effect of Nedocromil Sodium on Human Eosinophil Activation (2012) (1)
Specific and Nonspecific Triggers in Bronchial Asthma (1985) (1)
Homoeopathy and hayfever (1991) (1)
Cells in acute and chronic inflammation. (1987) (1)
Activated peripheral blood CD4 and CD8 T-lymphocytes in childhood asthma (1993) (1)
What’s in a name? First use of the term ‘allergy’ (2013) (1)
Was Thomas Wharton Jones Frs, Assistant to the Infamous Dr Knox, the First to Recognise the Blood Eosinophil? (2019) (1)
Allergy and allergic diseases : with a view to the future/ scientific editor, A. B. Kay (2000) (1)
Pharmacological modulation of human eosinophil leukotriene C4 production (1984) (1)
Allergy testing in supermarkets: Misleads susceptible people (1994) (1)
Persistence of Airway Hyper-Responsiveness (AHR) after Resolution of Bronchial Mucosal Inflammation Following Allergen Inhalation Challenge in Mild Asthmatics (2006) (1)
MECHANISMS OF ALLERGIC ASTHMA : A TH2 DISEASE (1999) (1)
Mesangiocapillary Glomerulonephritis: Some Correlations Between Ultrastructure and Complement Profiles (1976) (1)
Chromatographie and Electrophoretic Properties of Synthetic Human Fibrinopeptides (1974) (1)
Immunological aspects of chronic asthma. (1987) (1)
S41 Expression of functional receptor activity modifying protein (RAMP)-1 by airway epithelial cells with dysregulation in asthma (2010) (1)
Allergen-induced leukotriene production in allergic rhinitis (1984) (1)
Announcement (1996) (1)
Mediators of hypersensitivity in exercise-induced asthma. (1983) (1)
212 Corticosteroids and monocyte activation in bronchial asthma (1985) (1)
The eosinophil in allergic lung disease (1975) (1)
Contents, Vol. 94, 1991 (1991) (1)
Human transfer factor prepared by dialysis, ultrafiltration and gel chromatography: biological activity in local transfer of skin sensitivity. (1977) (1)
178 Effects of drugs on exercise-induced dual asthmatic responses (1985) (1)
356 Alterations in granulocyte function when human blood leucocytes are incubated with anti-IgE (Reversed-type anaphylaxis) (1985) (1)
Mast cells and their mediators in the pathogenesis of asthma. (1983) (1)
Chapter 12 – Eosinophil-Mediated Tissue Remodeling and Fibrosis (2013) (1)
Glucocorticoid Pharmacokinetics, Glucocorticoid Receptor Characteristics, and Inhibition of Peripheral Blood T Cell Proliferation by Glucocorticoids In vtuo:» (1991) (1)
Mediators in Exercise and Late Asthma (1983) (1)
240 Inhibition of the allergen-induced late phase asthmatic reaction by oral cyclosporin A (CsA) (1996) (1)
Anthony J Frew. (2018) (1)
THE TREATMENT OF HYMENOPTERA SENSITIVITY WITH WHOLE BODY EXTRACT: A FALSE SENSE OF SECURITY (1981) (1)
314 Leukotriene C4 generation by human eosinophils after stimulation with IgG-coated particles (1985) (1)
‘Allergy. The History of a Modern Malady’ by Mark Jackson (2006) (1)
31 Sulphidopeptide leukotrienes and LTB4 in nasal secretions and nasal polyposis (1985) (1)
THE ROLE OF T CELLS IN ALLERGIC DISEASES (1996) (0)
Subject Index Vol. 122, 2000 (2000) (0)
Induction of fibroblast type I procollagen by human eosinophils (2002) (0)
Contents Vol. 122, 2000 (2000) (0)
Explorer Enhanced expression of human monocyte complement ( C 3 b ) receptors by chemoattractants (2017) (0)
6. EOSINOPHIL PRODUCTION AND INFILTRATION (1996) (0)
559 Antigen and restriction specificity of human T lymphocyte clones reactive with dermatophagoides farinae (house dust mite) (1988) (0)
744 Interleukin-9 enhances human eosinophil development, and is increased in asthma (1999) (0)
High molecular weight neutrophil chemotactic activity in asthma and related disorders. (1986) (0)
The contribution of Tony Frew (1955‐2018) to our understanding of Late‐Phase Allergic Reactions (2019) (0)
Exercise and asthma (1988) (0)
468 Induction of cutaneous and bronchial hyporesponsiveness by short allergen-derived peptides (2000) (0)
Bronchial asthma and the neutrophil chemotactic factor (1982) (0)
Treatment of bee venom allergic subjects with phospholipase A2 T Cell epitope peptides results in iincreased expression of mRNA encoding suppressor of cytokine signalling (SOCS) 3 and a transient increase in allergen-specific IgG/G4 (2005) (0)
The Role of Adhesion in Eosinophil Accumulation and Activation in Asthma (2019) (0)
Is eotaxin-induced neutrophil infiltration in human skin CCR3-dependent? (2002) (0)
Phenotypic studies in human tuberculin and allergen induced skin reactions (1990) (0)
154 Relative eosinophil and neutrophil chemotactic activities (1988) (0)
The Evolving Role of T Cells in Allergic Disease (1999) (0)
Clinical rresponse tto c cyclosporin iin c chronic s severe a asthma is a associated w with rreduction iin s serum s soluble interleukin-2 rreceptor c concentrations (1995) (0)
287 Neutrophil chemotactic activity in laboratory animal-induced asthma (1985) (0)
Abstracts from the Immunopathology of Asthma Symposium, London, U.K., 5 February 1991 (1991) (0)
255 Exercise-induced late asthamatic reactions (1983) (0)
A call for more clinical papers (1991) (0)
ACTIVITY FOR HIrMAN •EUTROPttILS BY TI~E CONVERSION OF HUMAN PREKALLIKREIN TO KALLIKREIN BY ALLEN P. KAPLAN,$ A. B. KAY,§ ANI~ (2003) (0)
Immunotherapy and hay fever: Authors' reply (1991) (0)
T Lymphocyte/Eosinophil Interactions in Atopic Asthma: Critical Role for Interleukin-5 (1993) (0)
Scientific Foundations of Respiratory Medicine (1982) (0)
Eosinophil leucocytes: recruitment, localization and function in immediate-type hypersensitivity. (1977) (0)
331 Late-phase allergic, skin reactions in man: Are fibrin and complement involved? (1991) (0)
Clinical Patterns of Bronchial Asthma in Relation to Complement Components (1976) (0)
Anti-IL-5 treatment (mepolizumab) reduces eosinophil-associated TGF-β: Relationship to deposition of extracellular matrix proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics (2004) (0)
Mediators of Type I Hypersensitivity in the Sputum of Symptomatic Young Cigarette Smokers (1980) (0)
In Honour of Paul Kallós (1987) (0)
A monocytefunction test(complement receptor enhancement) toassesstheextent ofbronchial carcinoma (1987) (0)
Peptide-based allergen immunotherapy is associated with improvements in symptoms of rhinitis (2004) (0)
Allergen, IgE and Mast-Cell-Directed Therapies: An Overview (2001) (0)
From Molecular Science to the Treatment of Allergy (1999) (0)
Inhibition of monocyte complement receptor enhancement by low molecular weight material from human lung cancers (2006) (0)
From Molecular Science to the Treatment of Allergy (1999) (0)
III. APPEARANCE OF CI-IEMOTACTIC ACTIVITY FOR HIrMANEUTROPttILS (1972) (0)
A POSSIBLE DIAGNOSTIC AID IN PATIENT'S WITH AN EOSINOPHILS (1977) (0)
and Remodeling in Human Atopic Skin Tissue Eosinophilia and Markers of Repair The Relationship Between Allergen-Induced (2002) (0)
Neutrophils and the Asthmatic Response (1987) (0)
Asthma, Eosinophils, and Interleukin-5 (2019) (0)
Chemotaxis of eosinophil leukocytes in relation to immediate-type hypersensitivity and the complement system. (1974) (0)
Human mucosal mast cells and their mediators (1986) (0)
Inhibition of monocyte complement receptor enhancement by low molecular weight material from human lung cancers (2006) (0)
asthmatic reactions in atopic subjects mucosal inflammation in T cell peptide-induced Airway hyperresponsiveness and bronchial (2008) (0)
Contents, Vol. 82, 1987 (1987) (0)
Expression of CGRP and its Functional Receptor Activity Modifying Protein (RAMP)-1 in Late-Phase Allergic Reactions in Atopics (2011) (0)
Session 1. Environmental factors in allergic disorders (2004) (0)
Editorial announcement (1985) (0)
1 – T-Lymphocytes in Allergic Asthma (1993) (0)
Histamine-dependent upregulation of eotaxin by endothelial cells in vitro and in the skin of atopic allergic volunteers (2003) (0)
Neutrophil and Eosinophil Chemotaxis and Cutaneous Inflammatory Reactions (1989) (0)
84 Parenteral and enteral release of leukotrienes and rmcpii after systemic anaphylaxis in Nippostrongylus brasiliensis-primed rats (1985) (0)
ACTIVITY FOR HIrMAN •EUTROPttILS BY TI~E CONVERSION OF HUMAN PREKALLIKREIN TO KALLIKREIN BY ALLEN P. KAPLAN,$ A. B. KAY,§ ANI~ (2003) (0)
Subject Index, Vol. 4, Supplement 1, 1991 (1991) (0)
Biographical Sketch of Dr. Alec H. Sehon (1991) (0)
Enhanced cysteinyl. leukotriene but not prostanoid expression in induced sputum due to allergen inhalational. (1999) (0)
Comprar RNA Purification and Analysis: Sample Preparation, Extraction, Chromatography | A. Barry Kay | 9783527321162 | Wiley (2009) (0)
Session 2. Genetic factors and immune tolerance in allergic disorders (2004) (0)
Edinburgh Research Explorer Inhibition of monocyte complement receptor enhancement by low molecular weight material from human lung cancers (2006) (0)
Session 7. Treatment and prevention of asthma and allergic disorders (2004) (0)
Early History of Granulocytes (2016) (0)
Immunosuppression in Chronic Asthma. (1992) (0)
CYCLOSPORIN A AND RELATED DRUGS (1993) (0)
464 CD4+ but not CD8+ T cells transfer allergic airway hyperresponsiveness (AHR) in BN-rats (1996) (0)
214 Effects of wasp venom immunotherapy on antigen-induced infiltration of inflammatory cells and expression of Th1/Th2-type and regulatory cytokines (2000) (0)
Studies on allergy and inflammation (1979) (0)
Discussuion Session 4. 'Evergreen' mediators in asthma (2004) (0)
Eosinophilopoiesis: IL-5R α is upregulated by IL-5 and IL-9 during eosinophil development, and CD34/IL-5Rα cells can be detected in the airway in asthma☆ (2000) (0)
277 Mediator release in asthma after allergen inhalation, treadmill exercise, isocapnic hyperventilation and methacholine challenge (1985) (0)
ENHANCEMENT OF GRANULOCYTE-MEDIATED KILLING OF SCHISTOSOMULA OF SCHISTOSOMA-MANSONI BY BASOPHIL PRODUCTS (1984) (0)
530 T lymphocyte subsets in human late-phase skin reactions (1988) (0)
Allergy and allergic diseases. Volume 2: allergic diseases, etiology, diagnosis and treatment. (2008) (0)
Isolated late asthmatic reactions provoked by inhalation of T-cell peptide epitopes are associated with bronchial mucosal infiltration of CD4+ T cells and increased airway hyperresponsiveness☆ (2004) (0)
Expression of the growth factors TGF-β, IGF-I, VEGF, PDGF-A and NGF by human basophils (2002) (0)
Human Atopic and Nonatopic Volunteers Reactions Following Cutaneous Injection in Features of Early-and Late-Phase Allergic Neutrophils , and Macrophages As Well As Basophils , Induce Recruitment of Eosinophils , Eotaxin ( CCL 11 ) and Eotaxin-2 ( CCL 24 ) (2002) (0)
The effect of age on the susceptibility of schistosomula of Schistosoma mansoni to damage by human eosinophils and neutrophils, in vitro. (1985) (0)
Session 10. Immune therapy and prevention: Is it just around the corner? (2004) (0)
Activin and TGF- β signalling pathways are activated after allergen challenge in mild asthma (2015) (0)
265 Antigen-induced neutrophil chemotactic activity (NCA) derived from cloned human T lymphocytes (1988) (0)
Contents, Vol. 99, 1992 (1992) (0)
Intracutaneous eotaxin and eotaxin-2 induces mRNA expression of IL-4, IL-5, eotaxin and eotaxin-2 in human atopic and non-atopic subjects (2002) (0)
Neutrophils and Eosinophils in IgE-Dependent Allergic Tissue Reactions (1982) (0)
Pathology of mild, severe, and fatal asthma. Discussion (1996) (0)
Eosinophils: role in asthma, allergy and parasite immunity. (1985) (0)
Notice of duplicate publication. (1997) (0)
1. CYCLOSPORIN A IN CHRONIC SEVERE STEROID-DEPENDENT ASTHMA (1991) (0)

This paper list is powered by the following services:

Other Resources About Barry Kay

en.wikipedia.org

What Schools Are Affiliated With Barry Kay ?

Barry Kay is affiliated with the following schools:

Barry Kay 's Academic­Influence.com Rankings